Recruiting
Phase 1

AB248 & Pembrolizumab

Sponsor:

Asher Biotherapeutics, Inc.

Code:

NCT05653882

Conditions

Solid Tumor

Non Small Cell Lung Cancer

Melanoma

Squamous Cell Carcinoma of Head and Neck

Renal Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AB248

pembrolizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information